Suppr超能文献

美国老年亚裔成年人的骨质疏松症和骨折风险。

Osteoporosis and Fracture Risk among Older US Asian Adults.

机构信息

Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612, USA.

The Permanente Medical Group, Oakland, CA, USA.

出版信息

Curr Osteoporos Rep. 2023 Oct;21(5):592-608. doi: 10.1007/s11914-023-00805-7. Epub 2023 Aug 5.

Abstract

PURPOSE OF REVIEW

This review summarizes the current knowledge regarding osteoporosis and fracture among older US Asian adults.

RECENT FINDINGS

Asian adults have lower (areal) bone density than non-Hispanic White adults and thus are more likely to be diagnosed and treated for osteoporosis, despite their lower risk of hip fracture. The latter may relate to favorable characteristics in hip geometry, volumetric bone density, and bone microarchitecture; lower risk of falls; and other clinical factors. The fracture risk calculator FRAX accounts for the lower risk of hip fracture among US Asian adults. However, data on major osteoporotic fracture risk remain limited. Fracture rates also vary by Asian subgroup, which may have implications for fracture risk assessment. Furthermore, among women receiving bisphosphonate drugs, Asian race is a risk factor for atypical femur fracture, an uncommon complication associated with treatment duration. Recent clinical trial efficacy data pertaining to lower bisphosphonate doses and longer dosing intervals may be relevant for Asian adults. More research is needed to inform osteoporosis care of US Asian adults, including risk-benefit considerations and the optimal duration of bisphosphonate treatment. Greater evidence-based guidance for primary fracture prevention among US Asian adults will ensure health equity in the prevention of osteoporotic fractures.

摘要

目的综述

本文总结了目前关于美国亚裔老年人骨质疏松症和骨折的相关知识。

最新发现

尽管美国亚裔髋部骨折风险较低,但他们的骨密度(面积)比非西班牙裔白人成年人低,因此更有可能被诊断和治疗骨质疏松症。后者可能与髋部几何形状、体积骨密度和骨微观结构的有利特征、较低的跌倒风险以及其他临床因素有关。骨折风险计算器 FRAX 考虑到了美国亚裔髋部骨折风险较低的因素。然而,关于主要骨质疏松性骨折风险的数据仍然有限。骨折率也因亚裔亚组而异,这可能对骨折风险评估有影响。此外,在接受双磷酸盐药物治疗的女性中,亚洲种族是股骨非典型性骨折的一个风险因素,这是一种与治疗时间有关的罕见并发症。最近与较低双磷酸盐剂量和更长给药间隔相关的临床试验疗效数据可能与亚洲成年人有关。需要更多的研究来为美国亚裔成年人提供骨质疏松症护理,包括风险效益考虑和双磷酸盐治疗的最佳持续时间。为美国亚裔成年人提供更多基于证据的一级骨折预防指南,将确保在预防骨质疏松性骨折方面实现健康公平。

相似文献

1
Osteoporosis and Fracture Risk among Older US Asian Adults.美国老年亚裔成年人的骨质疏松症和骨折风险。
Curr Osteoporos Rep. 2023 Oct;21(5):592-608. doi: 10.1007/s11914-023-00805-7. Epub 2023 Aug 5.
6
Bisphosphonate use after clinical fracture and risk of new fracture.临床骨折后使用双膦酸盐与新发骨折风险。
Osteoporos Int. 2018 Apr;29(4):937-945. doi: 10.1007/s00198-017-4367-7. Epub 2018 Feb 3.

引用本文的文献

5
senescence and senolytic functional assays.衰老和衰老细胞溶解功能测定
Biomater Sci. 2025 Jun 25;13(13):3509-3531. doi: 10.1039/d4bm01684j.

本文引用的文献

4
Heterogeneity in Obesity Prevalence Among Asian American Adults.亚裔美国人成年人中肥胖患病率的异质性。
Ann Intern Med. 2022 Nov;175(11):1493-1500. doi: 10.7326/M22-0609. Epub 2022 Oct 4.
9
The clinician's guide to prevention and treatment of osteoporosis.临床医生骨质疏松症防治指南。
Osteoporos Int. 2022 Oct;33(10):2049-2102. doi: 10.1007/s00198-021-05900-y. Epub 2022 Apr 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验